Structure Therapeutics (NASDAQ:GPCR) Stock Price Down 3.4%Ticker Report • about 1 month ago
Structure Therapeutics Inc. (NASDAQ:GPCR Get Free Report) fell 3.4% during trading on Wednesday . The company traded as low as $40.66 and last traded at $40.72. 61,403 shares traded hands...
Share to Feed
Structure Therapeutics Inc. (NASDAQ:GPCR Get Free Report)s share price gapped up prior to trading on Thursday . The stock had previously closed at $38.63, but opened at $41.10...
SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for...
Topline GSBR-1290 Phase 2a 12-week obesity data, as well as data from formulation bridging and titration optimization study, on track for latter half of the second quarter 2024 Phase 2b study in...
Fmr LLC raised its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR Free Report) by 28.5% in the 3rd quarter, according to the company in its most recent disclosure with the...
Structure Therapeutics Inc. (NASDAQ:GPCR Get Free Report) has been assigned a consensus recommendation of Buy from the seven ratings firms that are currently covering the firm...
TD Asset Management Inc boosted its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR Free Report) by 109.3% in the third quarter, according to the company in its most recent 13F...